Abbott Laboratories' said on Monday it had received clearance to market the smallest version of its fastest-growing low-cost diabetes monitoring product in the European Union.

Benchmark started Abbott Laboratories with a Buy rating and a $145 price target, calling the diversified healthcare company a steady performer in a volatile global environment.

Freestyle football isn’t just about showing off—it’s about creativity, control, and confidence. In this video, we break down three iconic freestyle tricks that are fun to learn and surprisingly ...

Abbot⁠t Labor‌atories (NYSE​:ABT) has lo‌ng⁠ been a household name in the healthc‌are w‍o‌rl‍d, offering pr‌o‍ducts th​at ...

ABT's strong Nutrition, Diabetes Care and EPD growth fuel momentum, but macro and currency headwinds challenge its outlook.

Abbott Laboratories recently received Health Canada approval for the Esprit BTK Everolimus Eluting Resorbable Scaffold System ...

AMD, Abbott and Micron showcase strong momentum as AI demand, medical innovation and memory recovery drive growth prospects.

In addition to strong earnings, Eli Lilly and Company (NYSE:LLY) has also been returning value to shareholders for years. The ...

Here's how Android 17's new "Medical" profile will streamline setup and improve reliability for medical devices.

Detailed price information for Adv Micro Devices (AMD-Q) from The Globe and Mail including charting and trades.

CAIRE’s FreeStyle Comfort portable oxygen concentrator with proprietary autoSAT technology is now available in the United States.

Glooko plans to develop an end-to-end ‘hospital-to-home’ care support provision for diabetes patients through the resources it inherits with the purchase of Monarch.